4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001635088-26-000038
CEO sold 289,774 shares at $29.16 ($8,449,810)
From the SEC's structured data for this filing
Trades in this filing
Gline Matthew · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-16 | Sale : show line 1 in the form | −289,774 | $29.16 | $8,449,810 | 16,736,116 | D |
| Open-market sales · 289,774 sh · avg $29.16 · $8,449,810 | ||||||
Loading xslF345X06/wk-form4_1776724041.xml…